News & Events
Neurotar presents in the CNS category during Bio Europe Spring in Barcelona, March 11-13, 2013
Contact us via partnering software or directly to schedule a meeting.
Neurotar presents at the Swiss-Scandinavian Bio Business Seminar in Zurich on February 12, 2013
We will be in the area from February 11th to 14th. We are happy to meet at the seminar. One meeting slot is still open on the 14th. Contact us as soon as possible.
Neurotar’s team swings by Stockholm, Sweden on February 7-8, 2013
Neurotar’s Katja Karelina (CEO) and Leonard Khiroug (CSO) will be in Stockholm on February 7-8. One meeting slot is still available. Please contact us as soon as possible.
Neurotar presents at the Enterprise Finland Venture Forum on 24.1.2013 in Espoo, Finland
Investors are welcome to schedule meetings with Katja Karelina at the venue or to visit Neurotar during their stay in Helsinki. Contact Katja directly with inquiries.
Neurotar reaches the break even point at the end of 2012
Neurotar’s sales increased by a factor of 10 in 2012 compared to 2011. Sales revenues come mostly from service provision to companies located outside of Finland. Two of Neurotar’s clients are top ten pharmaceutical companies. Approximately one quarter of revenues comes from cosmetics.
Neurotar presents at the Bio Europe conference in Hamburg, November 12-14, 2012
Neurotar presentation in the Biomarker category focuses on the ways in which Neurotar’s services aid biomarker developers and highlights cooperation with the Swedish BioChromix AB in the area of biomarker development for Alzheimer’s.
Neurotar exhibits at Biotech Outsourcing Strategies (BOS) event in London on September 25, 2012
Neurotar completes final round of angel investment in August 2012
In total, € 0,5 Mil. have been invested into Neurotar by two angel investors during 2010-2012. The investment was used to build up Neurotar’s infrastructure and provide working capital.
In Vivo Microscopy Symposium organized with Neurotar’s help on May 23-25, 2012 in Helsinki attracted more than 100 participants from global industry and academia
The focus of 2012 Symposium was on CNS. The feedback was overwhelmingly positive. In response to the requests of this year’s attendees, next year’s topics will include data analysis and skin imaging.